TrialThe journal of allergy and clinical immunology. In practice2025

Long-Term Efficacy and Safety of Benralizumab Treatment for PDGFRA-Negative Hypereosinophilic Syndrome.

Fei Li Kuang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.